| Literature DB >> 10408633 |
N Magy1, B Cribier, C Schmitt, B Ellero, D Jaeck, K Boudjema, P Wolf, N Labouret, M Doffoel, A Kirn, F Stoll-Keller.
Abstract
The risk factors for clinical recurrent hepatitis C in liver transplant recipients are not clearly defined. It has been suggested that the corticosteroids included in the treatments of patients undergoing allograft rejection might induce acute hepatitis by increasing HCV replication. In this study we investigated the effects of corticosteroid boluses on HCV viremia in liver allograft recipients treated for acute rejection. Since we had previously developed a model of HCV replication in peripheral blood mononuclear cells (PBMC) in vitro, we also studied the effects of corticosteroids on HCV replication in vitro. A transient peak of HCV viremia was observed in patients treated with corticosteroid boluses for an acute allograft rejection. In the cell cultures, corticosteroids induced an increase of the total amount of viral RNA detectable. Our results demonstrate that corticosteroids induce an increase of hepatitis C virus replication in vivo and in vitro.Entities:
Mesh：
Substances：
Year: 1999 PMID： 10408633 DOI： 10.1016/s0192-0561(99)00005-3
Source DB: PubMed Journal: Int J Immunopharmacol ISSN： 0192-0561